from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3621c/PPE65

LFCtreatmentdescriptionclass of inhibitor

0.970

Amikacinug/mL Amikacintranslation

0.584

Cap5-10ug/mL Capreomycintranslation

0.354

Rox10-50 ug/mL Roxithromycintranslation

0.989

SM2-5 ug/mL Streptomycintranslation

0.447

Tet5-10 ug/mL Tetracyclinetranslation

0.961

Rif0.2-5ug/mL Rifampicintranscription

0.455

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.793

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.408

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.252

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.062

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.266

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.095

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.089

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.797

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.361

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.361

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.190

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.436

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.152

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.524

Nigericin50 uM Nigericinrespiration

0.361

TRC10-150 ug/mL Triclosanrespiration

0.151

TRZ10-25 ug/mL Thioridazinerespiration

1.905

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.373

menadione6-10 ug/mL Menadionerespiration

-1.040

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.322

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.175

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.726

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.617

NRP_1Non-replicating persistence stage 1dosRassociated

-0.189

Amp0.2mg/mL AmpicillincellWall

0.170

Cephalexin20-100 ug/mL CephalexincellWall

1.413

Cerulenin0.32-5 ug/mL CerulenincellWall

0.414

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.061

EMB10-20 ug/mL EthambutolcellWall

0.039

Eta12-40 ug/mL EthionamidecellWall

-0.169

INH0.2-0.4 ug/mL IsoniazidcellWall

0.292

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.248

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.625

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.929

BZA0.12 mg/mL BenzamidearomaticAmides

0.009

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.145

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.547

H2O24 mM hydrogen peroxideDNAdamaging

-0.022

Levo10 ug/mL LevofloxacinDNAdamaging

-0.295

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.195

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.441

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.474

UVUV-irradiationDNAdamaging

-0.313

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.125

Antimycin12.5-50 ug/mL Antimycin A?

-0.122

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.045

PA_110-50 ug/mL Antitubercular compound PA-1?

0.272

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.322

PA8240.2-2 ug/mL PA-824?

0.130

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.013

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.563

Verapamil50 uM Verapamil?

-0.233

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.564

methoxatin10-20 ug/mL Methoxatin?